Is emeis Société Anonyme (ENXTPA:EMEIS) Undervalued On Revenue Growth And 2026 Guidance?
emeis Société anonyme (ENXTPA:EMEIS) caught investor attention after reporting like-for-like revenue growth of 6.0% to the end of September 2026, alongside updated 2026 EBITDAR guidance and confirmation of its Latin American exit.
Against that operational backdrop, emeis Société anonyme’s share price has reacted sharply in the short term, with a 1-day share price return of 3.47% and a 7-day share price return of 6.70%. However, the 90-day share price return has still fallen 28.37%, and the 1-year total shareholder return is down 28.46%, so recent momentum looks more like a tentative rebound than a full change in trend as investors reassess revenue growth, guidance and the refocus on European assets.
See how emeis Société anonyme’s rebound story compares to other healthcare operators by reviewing our hand-picked shortlist of list of solid balance sheet and fundamentals (207 results).
Bulls see emeis Société anonyme cleaning up its portfolio and guidance, while bears point to deep long-term share price losses. Which side do the current valuation markers support next?
Most Popular Narrative: 37% Undervalued
Analysts following emeis Société anonyme see a narrative fair value of about €16.53 per share against a last close of €10.43. The story hinges on whether that gap can be justified by execution on occupancy, pricing and balance sheet repair.
Demographic driven growth in demand for long term care capacity across Europe, combined with limited public sector supply, positions emeis to selectively ramp up existing sites and pursue new asset light developments, in line with a 4 to 5 percent annual revenue growth target and an ambition for double digit EBITDA CAGR.
A structural shift to more disciplined, lower intensity development CapEx and partnership based real estate solutions may reduce capital intensity and interest costs. This could improve free cash flow generation and support deleveraging and earnings growth.
See why 1 investors see emeis Société anonyme as 37% undervalued.
Behind that story sits an 11.54% discount rate applied to emeis Société anonyme in the most followed narrative, paired with a fair value of €16.53 and a stated discount to fair value of 36.9%. The gap between the current €10.43 share price and that reference point reflects expectations around gradually improving occupancy, lighter capital spending and the ability to handle a high debt load while still moving losses closer to break even.
Result: Fair Value of €16.53 (UNDERVALUED)
Still, emeis Société anonyme faces two big pressure points: heavy leverage around €3.8b of net debt and ongoing political scrutiny of private elderly care across key markets.
Find out about the key risks to this emeis Société anonyme narrative.
Next Steps
Mixed on emeis Société anonyme after these updates or leaning one way already, but want to move quickly and rely on your own judgment rather than headlines alone? Start by weighing the 4 key rewards and 1 important warning sign.
Looking for more investment ideas beyond emeis Société anonyme?
Do not stop with just one turnaround story. Broaden your watchlist now with a few focused stock ideas that match how you like to balance risk and return.
- Target potential mispricing by scanning for companies that combine quality fundamentals with attractive valuations using the 195 high quality undervalued stocks.
- Strengthen your income stream by reviewing companies that appear built to sustain higher yields through the 228 dividend fortresses.
- Dial down portfolio stress by focusing on businesses that score well on resilience through the 228 resilient stocks with low risk scores.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com